After China probe, is AstraZeneca’s new US$2.5 billion plan a blueprint for foreign firms?

Mar 24, 2025 | INVESTING

After China probe, is AstraZeneca’s new US$2.5 billion plan a blueprint for foreign firms?

British-Swedish drug maker has gone from Beijing’s scrutiny to its praise, hailed as a sign of doing business in China.

RELATED ARTICLES

Sudan army chief declares capital Khartoum ‘free’ from inside presidential palace

Sudan army chief declares capital Khartoum ‘free’ from inside presidential palace

Mar 26, 2025 | INVESTING

Is the ‘China threat’ the last thing keeping Trump’s US and the rest of the West together?

Is the ‘China threat’ the last thing keeping Trump’s US and the rest of the West together?

Mar 26, 2025 | INVESTING

Trump presses ahead with 25% car tariffs, ratcheting up trade war

Trump presses ahead with 25% car tariffs, ratcheting up trade war

Mar 26, 2025 | INVESTING

Beijing would not attack Taiwan if it believed trade would suffer, senators hear

Beijing would not attack Taiwan if it believed trade would suffer, senators hear

Mar 26, 2025 | INVESTING

Why the US could lose more ground in Southeast Asia

Why the US could lose more ground in Southeast Asia

Mar 26, 2025 | INVESTING

Pin It on Pinterest

Sudan army chief declares capital Khartoum ‘free’ from inside presidential palace

Is the ‘China threat’ the last thing keeping Trump’s US and the rest of the West together?

Trump presses ahead with 25% car tariffs, ratcheting up trade war

Beijing would not attack Taiwan if it believed trade would suffer, senators hear

Why the US could lose more ground in Southeast Asia